• Fund Type: Unit Trust
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

AXA Framlington Biotech Fund

+ Add to Watchlist

FRABIOI:LN

132.10 GBp 0.000.00%

As of 00:59:30 ET on 10/24/2014.

Snapshot for AXA Framlington Biotech Fund (FRABIOI)

Year To Date: +28.80% 3-Month: +17.13% 3-Year: +42.26% 52-Week Range: 92.02 - 132.10
1-Month: +7.05% 1-Year: +36.91% 5-Year: +25.60% Beta vs NBI: 0.94

Mutual Fund Chart for FRABIOI

No chart data available.
  • FRABIOI:LN 132.10
  • 1M
  • 1Y
Interactive FRABIOI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FRABIOI

AXA Framlington Biotech Fund is an authorized unit trust incorporated in the United Kingdom. The aim of the Fund is to provide long-term capital appreciation The Fund will invest principally in equity securities of companies in the biotechnology, genomic and medical research industries worldwide.

Inception Date: 11-26-2001 Telephone: 44-207-374-4100
Managers: LINDEN THOMSON / GEMMA GAME
Web Site: www.axa-framlington.com

Fundamentals for FRABIOI

NAV (on 2014-10-24) 132.10
Assets (M) (on 2014-10-14) 361.89
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment 100.00

Dividends for FRABIOI

Dividend Type Omitted
Dividend Frequency Semi-Anl
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for FRABIOI

Front Load 5.50
Back Load 0.00
Current Mgmt Fee 1.75
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.95

Top Fund Holdings for FRABIOI

Filing Date: 09/30/2014
Name Position Value % of Total
Celgene Corp 614,950 35,936,200 9.400%
Gilead Sciences Inc 535,884 35,171,600 9.200%
Amgen Inc 344,326 29,819,400 7.800%
Vertex Pharmaceuticals Inc 325,733 22,555,700 5.900%
Biogen Idec Inc 103,089 21,026,500 5.500%
Illumina Inc 170,219 17,203,500 4.500%
Alexion Pharmaceuticals Inc 157,051 16,056,600 4.200%
Regeneron Pharmaceuticals Inc 67,075 14,909,700 3.900%
BioMarin Pharmaceutical Inc 300,746 13,380,500 3.500%
Salix Pharmaceuticals Ltd 119,058 11,469,000 3.000%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil